DE60024593D1 - Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthalten - Google Patents

Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthalten

Info

Publication number
DE60024593D1
DE60024593D1 DE60024593T DE60024593T DE60024593D1 DE 60024593 D1 DE60024593 D1 DE 60024593D1 DE 60024593 T DE60024593 T DE 60024593T DE 60024593 T DE60024593 T DE 60024593T DE 60024593 D1 DE60024593 D1 DE 60024593D1
Authority
DE
Germany
Prior art keywords
dietetic
cosmetic
cystein
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024593T
Other languages
English (en)
Other versions
DE60024593T2 (de
Inventor
Aglio Roberto Dall
Margherita Borgonovo
Carlo Introini
Pierangelo Melegari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNI CI Srl
Original Assignee
UNI CI Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNI CI Srl filed Critical UNI CI Srl
Publication of DE60024593D1 publication Critical patent/DE60024593D1/de
Application granted granted Critical
Publication of DE60024593T2 publication Critical patent/DE60024593T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60024593T 1999-03-05 2000-02-28 Pharmazeutische, diätetische kosmetische Zusammensetzungen, die Thioctsäure und Cystein enthalten Expired - Lifetime DE60024593T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI990460 1999-03-05
IT1999MI000460A IT1312377B1 (it) 1999-03-05 1999-03-05 Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
PCT/EP2000/001637 WO2000053176A1 (en) 1999-03-05 2000-02-28 Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine

Publications (2)

Publication Number Publication Date
DE60024593D1 true DE60024593D1 (de) 2006-01-12
DE60024593T2 DE60024593T2 (de) 2006-08-17

Family

ID=11382177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024593T Expired - Lifetime DE60024593T2 (de) 1999-03-05 2000-02-28 Pharmazeutische, diätetische kosmetische Zusammensetzungen, die Thioctsäure und Cystein enthalten

Country Status (7)

Country Link
EP (1) EP1156802B1 (de)
AT (1) ATE311874T1 (de)
AU (1) AU2915900A (de)
DE (1) DE60024593T2 (de)
ES (1) ES2254145T3 (de)
IT (1) IT1312377B1 (de)
WO (1) WO2000053176A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4182183B2 (ja) * 1999-08-24 2008-11-19 ディーエスエム アイピー アセッツ ビー．ブイ． 痩身用皮膚化粧料
US7736661B1 (en) * 2000-03-07 2010-06-15 Avon Products, Inc Method of treating skin conditions
AU2001242130A1 (en) * 2000-03-07 2001-09-17 Forbes Medi-Tech Inc. Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
WO2002013813A1 (en) * 2000-08-11 2002-02-21 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
US6423349B1 (en) * 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
AU2002221934A1 (en) * 2000-12-16 2002-06-24 Aventis Pharma Deutschland Gmbh Health promoting compositions
EP1214893A1 (de) * 2000-12-16 2002-06-19 Aventis Pharma Deutschland GmbH Zusammensetzungen zur Verbesserung der Gesundheit
DE10111053A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
CN1398838A (zh) * 2001-07-26 2003-02-26 中国人民解放军军事医学科学院放射医学研究所 二苯乙烯类化合物制备以及它们在治疗和预防糖尿病中的应用
WO2003037343A1 (en) * 2001-10-30 2003-05-08 Lonza Ag Composition comprising folic acid and carnitine useful to enhance male fertility
ES2419164T3 (es) * 2001-11-02 2013-08-19 The Regents Of The University Of California Composiciones para la prevención y el tratamiento de una enfermedad inflamatoria, una enfermedad autoinmune, y rechazo de trasplante
DE10305661A1 (de) * 2003-02-12 2004-08-26 Degussa Ag Darreichungsform zur Kolon-spezifischen Wirkstofffreisetzung
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US20050171027A1 (en) 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) * 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CA2553884C (en) 2004-01-28 2013-06-25 Nestec S.A. Nutritional composition for improving skin condition and preventing skin diseases
AU2005253766B2 (en) 2004-06-15 2010-11-11 The Boots Company Plc Haircare compositions and methods
RU2007132962A (ru) * 2005-02-04 2009-03-10 Петер ХЕГЕР (DE) Применение гидроксистильбенсодержащих активных веществ для профилактики и/или лечения остеопороза
DE102005005270A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Behandlung leichter bis mittelschwerer Depressionen und Angstzustände
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
AT503219B1 (de) * 2006-02-03 2008-07-15 Annerl Brigitte Kombinationspräparat auf basis von antioxidanzien zur verbesserung der samenqualität
NL2000008C2 (nl) * 2006-02-16 2007-08-17 Apo Pharmaceuticals Internat B Samenstelling en doseereenheid als voedingssupplement en voor de behandeling van retinis pigmentosa.
ITRM20060108A1 (it) 2006-03-03 2007-09-04 Colella Gino Composizioni a base di melatonina e sostanze immunostimolanti
EP1932542A1 (de) * 2006-12-15 2008-06-18 TIMA Foundation Antioxidantzusammensetzung und ihre Verwendung in Diabetes
DE102007013145A1 (de) * 2007-03-15 2008-09-18 Henkel Ag & Co. Kgaa Wellmittel mit Haarfaserstrukturanten
EP2694045B1 (de) 2011-04-01 2019-10-30 Iasomai AB Neue kombination mit n-acetyl-l-cystein und ihre verwendung
JP5777821B2 (ja) 2011-11-15 2015-09-09 ティーマ ファウンデーション 細胞傷害作用からの防御のための組成物
RU2495675C1 (ru) * 2012-06-26 2013-10-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет Министерства здравоохранения и социального развития РФ" Способ лечения угревой болезни
BR112017017432A2 (pt) * 2015-02-17 2018-04-03 Ares Trading S.A. ?composição líquida tópica?
WO2024099688A1 (en) * 2022-11-11 2024-05-16 Unilever Ip Holdings B.V. Personal care composition
WO2024099702A1 (en) * 2022-11-11 2024-05-16 Unilever Ip Holdings B.V. A personal care composition
WO2024099690A1 (en) * 2022-11-11 2024-05-16 Unilever Ip Holdings B.V. A personal care composition
WO2024099689A1 (en) * 2022-11-11 2024-05-16 Unilever Ip Holdings B.V. A personal care composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4630M (de) * 1965-06-09 1966-11-28
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
US6013632A (en) * 1997-01-13 2000-01-11 Emory University Compounds and their combinations for the treatment of influenza infection
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
IT1312377B1 (it) 2002-04-15
ITMI990460A1 (it) 2000-09-05
AU2915900A (en) 2000-09-28
WO2000053176A1 (en) 2000-09-14
EP1156802A1 (de) 2001-11-28
ATE311874T1 (de) 2005-12-15
EP1156802B1 (de) 2005-12-07
ES2254145T3 (es) 2006-06-16
DE60024593T2 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
DE60024593D1 (de) Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthalten
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
DE69530389D1 (de) Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen
DK1331927T3 (da) Topisk komposition der indeholder mindst et D-vitamin eller en D-vitamin analog og mindst et kosttikosteroid
IL121126A0 (en) Method of increasing expression of molecular chaperon by an eukarytic cell
SE0001899D0 (sv) New compounds
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
GEP20012578B (en) (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
PT1047397E (pt) Composicoes topicas para aumento da producao de glutationa
NZ509276A (en) Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
AU7263591A (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
KR970025615A (ko) 암 전이 억제제
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
GEP19991871B (en) Thiol Derivatives with Metallopeptidase Inhibitory Activity
TR200100333T2 (tr) Bir karnitin ve bir karotenoit içeren antioksidan, antiproliferos bileşim
CY1106168T1 (el) Συνθεση για την προληψη και/ή θepαπεια αγγειακων ασθενειων που συνισταται απο προπιονυλ l-καρνιτινη και συνενζυμο q10
DE69819519D1 (de) Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
IL106107A (en) Imidazolyl-substituted cyclohexane derivatives, their preparation and pharmaceutical compositions containing them
DK0749977T3 (da) Nye 17-hydroxyiminoalkyl- og 17-hydroxyiminomethylalkenylcyclopentanperhydrophenanthrenderivater aktive på det cardiovaskul
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
AU2003301513A1 (en) Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
BR9508521A (pt) Inibição da biossintese de leucotrienos com derivados de uréia
UA64074C2 (uk) Кардіопротекторний антиоксидантний засіб "елгацин"
KR970000215A (ko) 대추추출물을 유효성분으로 하는 치주질환 예방 및 치료제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition